Covid vaccine with no 'serious side-effects', but India faces cold-reality

Last Updated: Nov 19 2020 | 1:31 PM IST

Connect with us

Global drugmakers Pfizer and BioNTech have said that their Covid-19 vaccine was found 95 per cent effective in the final analysis of the Phase 3 trial, including in people aged over 65 years, paving the way for the companies to apply for emergency authorisation from US regulators within days. Based on current projections, the companies expect to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses by the end of 2021. The major announcement comes just two days after leading biotechnology company Moderna said on Monday its virus vaccine had an efficacy rate of 94.5 per cent. But will the Pfizer vaccine be available in India? Watch the video